Company Profile
Alphatec Holdings, Inc. Stock Price, News & Catalysts
- Ticker:
- ATEC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
9.45 USD (-3.47%)
Close
Last updated: August 17, 2026
1.15B USD
Market cap
Why the stock is moving
As of Aug 17, 2026, ATEC closed down 3.47% at $9.45. No new same-company headline was identified in the current news window.
Company overview
Business overview
Alphatec is a spine-focused medical device company with a growing portfolio of procedural and reconstructive products.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Alphatec sits in procedure-driven medtech.
Business Model Characteristics
Its revenue is driven by surgical adoption, product launches, and the expansion of its spine franchise.
Position Within the Biotechnology Landscape
Alphatec is a growth-oriented medtech name that trades on procedural adoption and operating execution.
Future catalysts
- Alphatec's catalysts are spine-procedure growth, EOS / surgical-platform adoption, and continued surgeon penetration. The company matters most when product-cycle execution turns into repeatable procedure share.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Alphatec Holdings, Inc. (ATEC)?
Alphatec Holdings, Inc. (ATEC) most recently closed at 9.45 USD, a -3.47% move versus the previous session.
What is the market cap of Alphatec Holdings, Inc. (ATEC)?
Alphatec Holdings, Inc. currently has a market capitalization of 1.15B USD on BioPharmSignal.
What does Alphatec Holdings, Inc. do?
Alphatec is a spine-focused medical device company with a growing portfolio of procedural and reconstructive products.
On which exchange is ATEC stock listed?
Alphatec Holdings, Inc. (ATEC) is associated with NASDAQ, United States, Biopharma.
What is Alphatec?
Alphatec's catalysts are spine-procedure growth, EOS / surgical-platform adoption, and continued surgeon penetration.
Which conditions is Alphatec Holdings, Inc. targeting with Alphatec?
Alphatec's catalysts are spine-procedure growth, EOS / surgical-platform adoption, and continued surgeon penetration.
How does Alphatec Holdings, Inc. describe recent progress with Alphatec?
Alphatec's catalysts are spine-procedure growth, EOS / surgical-platform adoption, and continued surgeon penetration.
What future catalysts are investors watching for Alphatec Holdings, Inc.?
Alphatec's catalysts are spine-procedure growth, EOS / surgical-platform adoption, and continued surgeon penetration. The company matters most when product-cycle execution turns into repeatable procedure share.